Portage Place, Air Canada Window Park: construction at Portage and Carlton
CTV's Harrison Shin gives an update on the current progress of the Portage Place redevelopment.
A construction project in Winnipeg is set to change the downtown landscape.
'It is part of an over a billion-dollar injection into our downtown, and it's going to be transformative,' said Sean Kavanagh, senior director of strategic communications of True North Real Estate and Development (TNRED).
The centre court, food court and skywalk at Portage Place were closed as of mid-July, while some of the existing retail stores will remain open.
TNRED intends to build a new building called 'Healthcare Centre of Excellence,' featuring multiple health care services.
'MRI, CT, diagnostics, day surgery, clinics, Pan Am Clinic—it will be a whole host of health services that will be available,' Kavanagh explained.
The plan also includes affordable housing with the Southern Chiefs' Organization, based on call to action #92 of the Truth and Reconciliation Commission of Canada.
The housing tower is projected to have more than 200 units, with up to 40 per cent of the units rented out at affordable rates.
Kavanagh said the construction's impact won't be too heavy.
'They're doing work at Air Canada Window Park next door, and the lane has been closed for a year anyway,' he said.
'Fortuitously, with the Transit Master Plan, the amount of busses actually coming down Portage Avenue has subsided substantially.'
Air Canada Window Park was fenced off in September 2024 and demolished. Construction has been ongoing, and the city says it is on track to be done by late September this year.
The redevelopment of Portage Place will unfold over the next three to four years, according to TNRED.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
2 minutes ago
- CTV News
Pfizer raises annual profit forecast
The Pfizer logo is displayed at the company's headquarters in New York. (AP Photo/Mark Lennihan, File) U.S. drugmaker Pfizer raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the second quarter, boosted by strong demand for its heart disease drug, Vyndaqel, and blood thinner, Eliquis. The drugmaker now expects to earn US$2.90 to $3.10 per share on an adjusted basis in 2025, compared with its previous expectations of $2.80 to $3.00 per share. Shares of the drugmaker rose 2.4 per cent in premarket hours. Pfizer said the new forecast includes an impact of 20 cents per share related to its recent licensing deal with China's 3SBio for experimental cancer treatment. Pfizer's results come at a time when the pharmaceutical industry is under pressure from U.S. President Donald Trump's administration to lower drug prices and is gearing up for 15 per cent tariffs on imports from the European Union. The drugmaker has said it had enough manufacturing capacity across its 10 sites in the United States to mitigate any impact from tariffs and is open to shifting some production to these existing facilities. Investors are also closely monitoring potential disruptions to Pfizer and other companies' vaccine portfolio from policy changes under U.S. Secretary of Health and Human Services, Robert F. Kennedy Jr., a known vaccine skeptic. Vaccines account for about 20 per cent of Pfizer's revenues. On an adjusted basis, Pfizer earned 78 cents per share in the second quarter, compared with analysts' expectations of 58 cents per share, according to LSEG data. (Reporting by Bhanvi Satija in Bengaluru and Michael Erman in New York; Editing by Anil D'Silva)
CTV News
2 minutes ago
- CTV News
Taco Bell parent Yum Brands misses estimates as spending slows, costs rise
Yum Brands missed analysts' estimates for second-quarter comparable sales and profit on Tuesday, hit by higher ingredient costs and muted demand that weighed on its businesses, including Taco Bell. Concerns over the impact of steep tariffs and economic growth have dented U.S. consumer spending on eating out, prompting fast-food chains, including Yum Brands, McDonald's and Burger King-owner Restaurant Brands, to launch budget-friendly meal deals to boost foot traffic. Taco Bell, which accounts for 38 per cent of the company's total revenue, rolled out meal boxes ranging from US$5 to $9. Still, its same-store sales growth in the U.S. — the biggest market — slowed to four per cent during the second quarter from five per cent a year earlier. Among other restaurant chains, Chipotle Mexican Grill cut its annual sales growth forecast and missed quarterly sales estimates on weak demand. Burger giant McDonald's, which is set to report results on Wednesday, warned of tough conditions in May on tariff uncertainty. U.S. President Donald Trump administration's unpredictable trade policies have also made it harder for businesses to plan operations, disrupted supply chains and increased costs. Yum's worldwide same-store sales rose two per cent during the quarter ended June 30, while analysts on average estimated a 2.37 per cent increase, according to data compiled by LSEG. Excluding items, it earned $1.44 per share, missing the estimate of $1.46 per share, owing to increased advertising and promotional expenses as well as still-high input costs. Total costs and expenses during the quarter were up 13 per cent. The company, which appointed insider Chris Turner as CEO in June, reported revenue of $1.93 billion, compared with the estimate of $1.94 billion. Its shares were marginally down at $145.81 in premarket trading. (Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Shilpi Majumdar)
CTV News
2 minutes ago
- CTV News
DuPont forecasts Q3 results above estimates on robust electronics, healthcare demand
The company name of Dupont appears above its trading post on the floor of the New York Stock Exchange. Industrial materials maker DuPont on Tuesday forecast current-quarter revenue and profit above Wall Street estimates, benefiting from strength in its electronics and healthcare segments, sending its shares up four per cent in premarket trading. The company also said it beat second-quarter profit estimates, which blunted the impact of tariffs. Demand for semiconductors has been rapidly increasing due to the proliferation of artificial intelligence-based technology, benefiting companies such as DuPont, which supports advanced chip manufacturing, packaging and assembly processes. For the third quarter, DuPont expects adjusted profit of US$1.15 per share, which is slightly above expectations of $1.14, according to data compiled by LSEG. The company forecast revenue of about $3.32 billion, also above analysts' average estimate of $3.30 billion. 'Our third-quarter guidance assumes about three per cent organic growth year-over-year with continued strength expected in healthcare, water and electronics end-markets, partially muted by continued weakness in construction end-markets,' DuPont CEO Antonella Franzen said. The Wilmington, Delaware-based company now expects full-year adjusted earnings of about $4.40 per share, compared with its previous forecast of $4.30 to $4.40 forecast. The company projected a $20 million tariff-related hit, or $0.04 per share, in the second half of 2025. The estimate is down from $60 million, or $0.10 per share, anticipated in the prior quarter, as companies continue to navigate fallout from U.S. President Donald Trump's sweeping trade policies. Earlier this year, DuPont had said that it planned to spin off its electronics business, the biggest in terms of turnover, by Nov. 1. Net sales at the electronics segment, which includes semiconductor technologies and interconnect solutions, rose to $1.17 billion during the April to June quarter from $1.10 billion a year earlier. Net sales at the industrials segment, which will remain with DuPont after the spinoff, rose marginally in the quarter to $2.09 billion. On an adjusted basis, DuPont posted a profit of $1.12 per share for the three months ended June 30, compared with analysts' estimates of $1.06. (Reporting by Pooja Menon in Bengaluru; Editing by Shinjini Ganguli)
